Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 5709INDUSTRY 3575NIH 425NETWORK 206OTHER_GOV 163FED 29UNKNOWN 28INDIV 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 12Lymphoid 4Gynecologic 3Breast 3Tumor-Agnostic 2Thoracic 2Sarcoma 2Plasma cell 2CNS 2Other solid neoplasm 1Other hematologic neoplasm 1Other 1Head & Neck 1Dermatologic 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Neutropenia 1Neoplasms 1Lung Neoplasms 1

Interventions

pegfilgrastim 1Mifepristone 1Corlux 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDIV × Interventional × Thoracic × Clear all
NCT02642939 2020-10-19

Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Check, Jerome H., M.D., Ph.D.

Phase 2 Terminated
3 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00050674 2012-12-27

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

Schwartzberg, Lee, M.D.

Phase 2 Completed
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡